Lomond Therapeutics

Biotech · Acquired

Small molecule drugs for oncology

lomondther.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
12
0 granted · 12 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2843CinCor Pharma—$143M
2844GRADIENT BIOMODELING, LLC——
2845Solid Biosciences—$109M
2846Lomond Therapeutics——
2847Cardurion Pharmaceuticals—$350M
2848DIGITAL NANOGENETICS, LLC——
2849RETINAL SOLUTIONS LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 12
  • SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOFapplication
  • Compounds Having N-ARYLPYRIMIDIN-2-AMINE Derivatives As Therapeutic Agentsapplication
  • Synthesis Of A Tetrahydroisoquinolin-pyrazoloquinolin Compound And Pharmaceutically Acceptable Salts Thereofapplication
  • Polymorphs And Solid Forms Of A Tetrahydroisoquinolin-pyrazoloquinolin Compound, And Pharmaceutical Compositions Thereofapplication
  • Substituted 1H-PYRAZOLO [4,3-C] Quinolines, Methods Of Their Preparation, And Use Thereofapplication
  • Compounds Having N-ARYLPYRIMIDIN-2-AMINE Derivatives As Therapeutic Agentsapplication
  • Compounds Having 1H-PYRAZOLO[4,3-C]PYRIDIN-6-AMINO As Therapeutic Agentsapplication
  • SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF THEIR PREPARATION, AND USE THEREOFapplication
  • Compounds Having N-ARYLPYRIMIDIN-2-AMINE Derivatives As Therapeutic Agentsapplication
  • Polymorphs And Solid Forms Of A Tetrahydroisoquinolinpyrazoloquinolin Compound, And Pharmaceutical Compositions Thereofapplication
  • Compounds Having 1H-PYRAZOLO[4,3-C]PYRIDIN-6-AMINO As Therapeutic Agentsapplication
  • Synthesis Of A Tetrahydroisoquinolin-pyrazoloquinolin Compound And Pharmaceutically Acceptable Salts Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.